Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0056) | |||||
---|---|---|---|---|---|
DME Name | Carboxylesterase 3 (CES3), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 3.1.1.1 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 4 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Malignant astrocytoma | Moderate hypermethylation | |||
Interaction Name | DNMT-CES3 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypermethylation p-value: 2.35E-53; delta-beta: 2.68E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the CES3 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Carboxylesterase 3. As a result, the interaction between DNMT and CES3 can moderatly affect the drug-metabolizing process of Carboxylesterase 3. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
DNA methyltransferase (DNMT) | Oligodendroglial tumour | Significant hypermethylation | |||
Interaction Name | DNMT-CES3 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 1.63E-03; delta-beta: 3.36E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CES3 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Carboxylesterase 3. As a result, the interaction between DNMT and CES3 can significantly affect the drug-metabolizing process of Carboxylesterase 3. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
DNA methyltransferase (DNMT) | Oligodendroglioma | Significant hypermethylation | |||
Interaction Name | DNMT-CES3 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 2.36E-57; delta-beta: 5.46E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CES3 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Carboxylesterase 3. As a result, the interaction between DNMT and CES3 can significantly affect the drug-metabolizing process of Carboxylesterase 3. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
DNA methyltransferase (DNMT) | Anaplastic pleomorphic xanthoastrocytoma | Moderate hypermethylation | |||
Interaction Name | DNMT-CES3 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypermethylation p-value: 2.38E-03; delta-beta: 2.13E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the CES3 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Carboxylesterase 3. As a result, the interaction between DNMT and CES3 can moderatly affect the drug-metabolizing process of Carboxylesterase 3. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2F37 Endocrine gland cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Pituitary adenoma | Significant hypermethylation | |||
Interaction Name | DNMT-CES3 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 4.84E-14; delta-beta: 4.83E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CES3 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Carboxylesterase 3. As a result, the interaction between DNMT and CES3 can significantly affect the drug-metabolizing process of Carboxylesterase 3. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases | |||||
ICD-11: 5B81 Obesity | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Obesity | Moderate hypomethylation | |||
Interaction Name | DNMT-CES3 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 5.85E-17; delta-beta: -2.70E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the CES3 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Carboxylesterase 3. As a result, the interaction between DNMT and CES3 can moderatly affect the drug-metabolizing process of Carboxylesterase 3. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.